AstraZeneca bets on in-house AI to speed up oncology research

AstraZeneca leverages internal AI to accelerate oncology research. As pharmaceutical research generates unprecedented data volumes, major companies like AstraZeneca deploy AI for analysis. The challenge shifts from whether AI can help to how deeply it should integrate into research and clinical workflows to optimize trial decisions and treatments.